P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin

Experimental Cell Research

Volumn 312, Issue 20, 2006, Pages 4056-4069

  Reyes Reyes, Merit E ^a   George, Margaret D ^a   Roberts, John D ^a   Akiyama, Steven K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Cell adhesion; Integrins; P selectin

Indexed keywords

CHIMERIC PROTEIN; FIBRONECTIN; IMMUNOGLOBULIN G; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; VERY LATE ACTIVATION ANTIGEN 5;

ARTICLE; BLOOD VESSEL WALL; CANCER CELL CULTURE; CARCINOMA CELL; CELL ACTIVATION; CELL ADHESION; CELL SPREADING; COMPLEX FORMATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR CELL;

CITRUS MACROPHYLLA;

EID: 37849188247     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.09.008     Document Type: Article

References (111)

1. Haier J., and Nicolson G. Tumor cell adhesion under hydrodynamic conditions of fluid flow. APMIS 109 (2001) 241-262
2. Goetz D., Ding H., Atkinson W., Vachino G., Camphausen R., Cumming D., and Luscinskas F. A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am. J. Pathol. 149 (1996) 1661-1673
3. Hood J., and Cheresh D. Role of integrins in cell invasion and migration. Nat. Rev., Cancer. 2 (2002) 91-100
4. Kaytes P., and Geng J. P-selectin mediates adhesion of the human melanoma cell line NKI-4: identification of glycoprotein ligands. Biochemistry 37 (1998) 10514-10521
5. Weiss L. Biomechanical interactions of cancer cells with the microvasculature during hematogenous metastasis. Cancer Metastasis Rev. 11 (1992) 227-235
6. Hynes R. Integrins: bidirectional, allosteric signaling machines. Cell 110 (2002) 673-687
7. Lee J., and Juliano R. Mitogenic signal transduction by integrin- and growth factor receptor-mediated pathways. Mol. Cell. Biol. 17 (2004) 188-202
8. Schwartz M., and Ginsberg M. Networks and crosstalk: integrin signalling spreads. Nat. Cell Biol. 4 (2002) E65-E68
9. van der Flier A., and Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 305 (2001) 238-285
10. Giancotti F., and Ruoslahti E. Integrin signaling. Science 285 (1999) 1028-1032
11. Liddington R., and Ginsberg M. Integrin activation takes shape. J. Cell Biol. 158 (2002) 833-839
12. Vuori K., and Ruoslahti E. Activation of protein kinase C precedes alpha 5 beta 1 integrin-mediated cell spreading on fibronectin. J. Biol. Chem. 268 (1993) 21459-21462
13. van Kooyk Y., van de Wiel-van Kemenade P., Weder P., Kuijpers T., and Figdor C. Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342 (1989) 811-813
14. Bazzoni G., and Hemler M. Are changes in integrin affinity and conformation overemphasized?. Trends Biochem. Sci. 23 (1998) 30-34
15. Vestweber D., and Blanks J. Mechanisms that regulate the function of the selectins and their ligands. Physiol. Rev. 79 (1999) 181-213
16. Mannori G., Crottet P., Cecconi O., Hanasaki K., Aruffo A., Nelson R., Varki A., and Bevilacqua M. Differential colon cancer cell adhesion to E-, P-, and L-selectin: role of mucin type glycoproteins. Cancer Res. 55 (1995) 4425-4431
17. Stone J., and Wagner D. P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J. Clin. Invest. 92 (1993) 804-813
18. Springer T. Traffic signals for lymphocytes recirculation and leukocyte emigration: the multistep paradigm. Cell 76 (1994) 301-314
19. Haier J., Nasralla M., and Nicolson G. b1-integrin mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow. Clin. Exp. Metastasis 17 (1999) 377-387
20. Mould A., Askari J., Craig S., Garratt A., Clements J., and Humphries M. Integrin alpha(4)beta(1)-mediate melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively splice IIICS region of fibronectin. J. Biol. Chem. 269 (1994) 27224-27230
21. Sawada R., Tsuboi S., and Fukuda M. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. J. Biol. Chem. 269 (1994) 1425-1431
22. Walz G., Aruffo A., Kolanus W., Bevilacqua M., and Seed B. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. Science 250 (1990) 1132-1135
23. Sammar M., Aigner S., Hubbe M., Schirrmacher V., Schachner M., Vestweber D., and Altevogt P. Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int. Immunol. 6 (1994) 1027-1036
24. Aigner S., Ramos C., Hafezi-Moghadam A., Lawrence M., Friederichs J., Altevogt P., and Ley K. CD24 mediates rolling of breast carcinoma cells on P-selectin. FASEB J. 12 (1998) 1241-1251
25. Aigner S., Sthoeger Z., Fogel M., Weber E., Zarn J., Ruppert M., Zeller Y., Vestweber D., Stahel R., Sammar M., and Altevogt P. CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood 89 (1997) 3385-3395
26. Labadia M., Jeanfavre D., Caviness G., and Morelock M. Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations. J. Immnol. 161 (1998) 836-842
27. Nicholson M., Barclay A., Singer M., Rosen S., and van der Merwe P. Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1. J. Biol. Chem. 273 (1998) 763-770
28. Rinko L., Lawrence M., and Guilford W. The molecular mechanics of P- and L-selectin lectin domains binding to PSGL-1. Biophys. J. 86 (2004) 544-554
29. Maly P., Thall A., Petryniak B., Rogers C., Smith P., Marks R., Kelly R., Gersten K., Cheng G., Saunders T., Camper S., Camphausen R., Sullivan F., Isogai Y., Hindsgaul O., and von U. P-selectin ligand biosynthesis. Cell 86 (1996) 643-653
30. Blanks J., Moll T., Eytner R., and Vestweber D. Stimulation of P-selectin glycoprotein ligand-1 on mouse neutrophils activates beta 2-integrin mediated cell attachment to ICAM-1. Eur. J. Immunol. 28 (1998) 433-443
31. Haller H., Kunzendorf U., Sacherer K., Lindschau C., Walz G., Distler A., and Luft F. T cell adhesion to P-selectin induces tyrosine phosphorylation of pp125 focal adhesion kinase and other substrates. J. Immunol. 158 (1997) 1061-1067
32. Levinovitz A., Muhlhoff J., Isenmann S., and Vestweber D. Identification of a glycoprotein ligand for E-selectin on mouse myeloid cells. J. Cell Biol. 121 (1993) 449-459
33. Sako D., Chang X., Barone K., Vachino G., White H., Shaw G., Veldman G., Bean K., Ahern T., Furie B., Cumming D., and Larsen G. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75 (1993) 1179-1186
34. Soltesz S., Powers E., Geng J., and Fisher C. Adhesion of HT-29 colon carcinoma cells to E-selectin results in increased tyrosine phosphorylation and decreased activity of c-src. Int. J. Cancer 71 (1997) 645-653
35. Akiyama S., Yamada S., Chen W., and Yamada K. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J. Cell Biol. 109 (1989) 863-875
36. LaFlamme S., Thomas L., Yamada S., and Yamada K. Single subunit chimeric integrins as mimics and inhibitors of endogenous integrin function in receptor localization, cell spreading and migration, and matrix assembly. J. Cell Biol. 126 (1994) 1287-1298
37. Miekka S., Ingham K., and Menache D. Rapid methods for isolation of human plasma fibronectin. Thromb. Res. 27 (1982) 1-14
38. Akiyama S., and Yamada K. The interaction of plasma fibronectin with fibroblastic cells in suspension. J. Biol. Chem. 260 (1985) 4492-4500
39. Whittard J., and Akiyama S. Activation of beta1 integrins induces cell-cell adhesion. Exp. Cell Res. 263 (2001) 65-76
40. Akiyama S., Yamada S., and Yamada K. Characterization of a 140-kD avian cell surface antigen as a fibronectin-binding molecule. J. Biol. Chem. 102 (1986) 442-448
41. Reyes-Reyes M., Mora N., Zentella A., and Rosales C. Phosphatidylinositol 3-kinase mediates integrin-dependent NF-kappaB and MAPK activation through separate signaling pathways. J. Cell. Sci. 114 (2001) 1579-1589
42. Arruffo A., Dietsch M., Wan H., Hellstrom K., and Hellstrom I. Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 2292-2296
43. Dardik R., Kaufmann Y., Savion N., Rosenberg N., Shenkman B., and Varon D. Platelets mediate tumor cell adhesion to the subendothelium under flow conditions: involvement of platelet GPIIb-IIIa and tumor cell alpha(v) integrins. Int. J. Cancer 70 (1997) 201-207
44. Dardik R., Savion N., Kaufmann Y., and Varon D. Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br. J. Cancer 77 (1998) 2069-2075
45. Sims P., Ginsberg M., Plow E., and Shattil S. Effect of platelet activation on the conformation of the plasma membrane glycoprotein IIb-IIIa complex. J. Biol. Chem. 266 (1991) 7345-7352
46. Woodside D., Liu S., and Ginsberg M. Integrin activation. Thromb. Res. 86 (2001) 316-323
47. Luque A., Gomez M., Puzon W., Takada Y., Sanchez-Madrid F., and Cabanas C. Activated conformations of very late activation integrins detected by a group of antibodies (HUTS) specific for a novel regulatory region of the common beta 1 chain. J. Biol. Chem. 271 (1996) 11067-11075
48. Paine E., Palmantier R., Akiyama S., Olden K., and Robert J. Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway. J. Biol. Chem. 275 (2000) 11284-11290
49. Danilkovitch-Miagkova A., and Zbar B. Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J. Clin. Invest. 109 (2002) 863-867
50. Katagiri K., Hattori M., Minato N., Irie S., Takatsu K., and Kinashi T. Rap1 is a potent activation signal for leukocyte function-associated antigen 1 distinct from protein kinase C and phosphatidylinositol-3-OH kinase. Mol. Cell. Biol. 20 (2000) 1956-1969
51. Trusolino L., Cavassa S., Angelini P., Ando M., Bertotti A., Comoglio P., and Boccaccio C. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J. 14 (2000) 1629-1640
52. Morris V., Koop S., MacDonald I., Schmidt E., Grattan M., Percy D., Chambers A., and Groom A. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin. Exp. Metastasis 12 (1994) 357-367
53. Morris V., Schmidt E., Koop S., MacDonald I., Grattan M., Khokha R., McLane M., Niewiarowski S., Chambers A., and Groom A. Effects of the disintegrin eristostatin on individual steps of hematogenous metastasis. Exp. Cell Res. 19 (1995) 571-578
54. MacDonald I., Groom A., and Chambers A. Cancer spread and micrometastasis development: quantitative approaches for in vivo models. Bioessays 24 (2002) 885-893
55. Irimura T., Nakamori S., Matsushita Y., Taniuchi Y., Todoroki N., Tsuji T., Izumi Y., Kawamura Y., Hoff S., and leary K. Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-LeX antigens. Semin. Cancer Biol. 4 (1993) 319-324
56. Takada A., Ohmori K., Yoneda T., Tsuyuoka K., Hasegawa A., Kiso M., and Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 53 (1993) 354-361
57. Dejana E., Martin-Padura D., Lauri S., Bernasconi M., and Bani A. Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an anti-body to Lewis fucosylated type I carbohydrate chain. Lab. Invest. 66 (1992) 324-330
58. Iwai K., Ishikura H., Kaji M., Sugiura H., Ishizu A., Takahashi C., Kato H., Tanabe T., and Yoshiki T. Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int. J. Cancer 54 (1993) 972-977
59. Laferriere J., Houle F., Taher M., Valerie K., and Huot J. Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells. J. Biol. Chem. 276 (2001) 33762-33772
60. Ludwig R., Boehme B., Podda M., Henschler R., Jager E., Tandi C., Boehncke W., Zollner T., Kaufmann R., and Gille J. Endothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis. Cancer Res. 64 (2004) 2743-2750
61. Majuri M., Mattila P., and Renkonen R. Recombinant E-selectin-protein mediates tumor cell adhesion via sialyl-Le(a) and sialyl-Le(x). Biochem. Biophys. Res. Commun. 182 (1992) 1376-1382
62. Karpatkin S., Pearlstein E., Salk P., and Yogeeswaran G. Role of platelets in tumor cell metastases. Ann. N. Y. Acad. Sci. 370 (1981) 101-118
63. Danen E., and Yamada K. Fibronectin, integrins, and growth control. J. Cell. Physiol. 189 (2001) 1-13
64. Jaskiewicz K., Chasen M., Robson S., Jaskiewicz K., Chasen M.R., and Robson S.C. Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease. Anticancer Res. 13 (1993) 2229-2237
65. Kemperman H., Driessens M., La Riviere G., Meijne A., and Roos E. Adhesion mechanisms in liver metastasis formation. Cancer Surv. 24 (1995) 67-79
66. Agrez M., and Bates R. Colorectal cancer and the integrin family of cell adhesion receptors: current status and future directions. Eur. J. Cancer 30A (1994) 2166-2170
67. Bates R., Bellovin D., Brown C., Maynard E., Wu B., Kawakatsu H., Sheppard D., Oettgen P., and Mercurio A. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Invest. 115 (2005) 339-347
68. Stallmach A., von Lampe B., Matthes H., Bornhoft G., and Riecken E. Diminished expression of integrin adhesion molecules on human colonic epithelial cells during the benign to malign tumour transformation. Gut 33 (1992) 342-346
69. Choy M., Richman P., Horton M., and MacDonald T. Expression of the VLA family of integrins in human intestine. J. Pathol. 160 (1990) 35-40
70. Koretz K., Schlag P., Boumsell L., and Moller P. Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am. J. Pathol. 138 (1991) 741-750
71. Lindmark G., Gerdin B., Pahlman L., Glimelius B., Gehlsen K., and Rubin K. Interconnection of integrins alpha 2 and alpha 3 and structure of the basal membrane in colorectal cancer: relation to survival. Eur. J. Surg. Oncol. 19 (1993) 50-60
72. Agrez M., Bates R., Mitchell D., Wilson N., Ferguson N., Anseline P., and Sheppard D. Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer. Br. J. Cancer 73 (1996) 887-892
73. Taverna D., Ullman-Cullere M., Rayburn H., Bronson R., and Hynes R. A test of the role of alpha5 integrin/fibronectin interactions in tumorigenesis. Cancer Res. 58 (1998) 848-853
74. Gong J., Wang D., Sun L., Zborowska E., Willson J., and Brattain M. Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells. Cell Growth Differ. 8 (1997) 83-90
75. Murillo C., Rychahou P., and Evers B. Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers. Surgery 136 (2004) 143-149
76. Newton S., Reeves E., Gralnick H., Mohla S., Yamada K., Olden K., and Akiyama S. Inhibition of experimental metastasis of human breast carcinoma cells in athymic nude mice by anti-α5β1 fibronectin receptor integrin antibodies. Int. J. Oncol. 6 (1995) 1063-1070
77. Crockett-Torabi E., Sulenbarger B., Smith C., and Fantone J. Activation of human neutrophils through L-selectin and Mac-1 molecules. J. Immunol. 154 (1995) 2291-2302
78. Simon S., Burns A., Taylor A., Gopalan P., Lynam E., Sklar L., and Smith C. L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin. J. Immunol. 155 (1995) 1502-1514
79. Simon S., Hu Y., Vestweber D., and Smith C. Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway. J Immunol. 164 (2000) 4348-4358
80. Lo S., Lee S., Ramos R., Lobb R., Rosa M., Chi-Rosso G., and Wright S. Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J. Exp. Med. 173 (1991) 1493-1500
81. Serve H., Yee N., Stella G., Sepp-Lorenzino L., Tan J., and Besmer P. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14 (1995) 473-483
82. Kinashi T., Asaoka T., Setoguchi R., and Takatsu K. Affinity modulation of very late antigen-5 through phosphatidylinositol 3-kinase in mast cells. J Immunol. 162 (1999) 2850-2857
83. Kinashi T., Escobedo J., Williams L., Takatsu K., and Springer T. Receptor tyrosine kinase stimulates cell-matrix adhesion by phosphatidylinositol 3 kinase and phospholipase C-gamma 1 pathways. Blood 86 (1995) 2086-2090
84. Ke Z., Lin H., Fan Z., Cai T., Kaplan R., Ma C., Bower K., Shi X., and Luo J. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2. Int. J. Cancer 119 (2006) 8-16
85. Klein G., Vellenga E., Fraaije M., Kamps W., and de Bont E. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit. Rev. Oncol. Hematol. 50 (2004) 87-100
86. Summy J., Trevino J., Baker C., and Gallick G. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas 31 (2005) 263-274
87. Xu L., Pathak P., and Fukumura D. Hypoxia-induced activation of p38 mitogen-activated protein kinase and phosphatidylinositol 3′-kinase signaling pathways contributes to expression of interleukin 8 in human ovarian carcinoma cells. Clin. Cancer Res. 10 (2004) 701-707
88. Yao J., Xiong S., Klos K., Nguyen N., Grijalva R., Li P., and Yu D. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20 (2001) 8066-8074
89. Zhang X., Lin M., van Golen K., Yoshioka K., Itoh K., and Yee D. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration. Breast Cancer Res. Treat. 93 (2005) 159-168
90. Mittelstadt P., Salvador J., Fornace A.J., and Ashwell J. Activating p38 MAPK: new tricks for an old kinase. Cell Cycle 4 (2005) 1189-1192
91. Schieven G. The biology of p38 kinase: a central role in inflammation. Curr. Top Med. Chem. 5 (2005) 921-928
92. Wymann M., and Marone R. Phosphoinositide 3-kinase in disease: timing, location, and scaffolding. Curr. Opin. Cell Biol. 17 (2005) 141-149
93. Wymann M., and Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436 (1998) 127-150
94. Goudreau N., Cornille F., Duchesne M., Parker F., Tocque B., Garbay C., and Roques B. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Nat. Struct. Biol. 1 (1994) 898-907
95. Ong S., Dilworth S., Hauck-Schmalenberger I., Pawson T., and Kiefer F. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20 (2001) 6327-6336
96. Shen T., and Guan J. Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett. 499 (2001) 176-181
97. Gong Q., Cheng A., Akk A., Alberola-Ila J., Gong G., Pawson T., and Chan A. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat. Immunol. 2 (2001) 29-36
98. Hayashi K., Shibata K., Morita T., Iwasaki K., Watanabe M., and Sobue K. Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J. Biol. Chem. 279 (2004) 40807-40818
99. Kallin A., Demoulin J., Nishida K., Hirano T., Ronnstrand L., and Heldin C. Gab1 contributes to cytoskeletal reorganization and chemotaxis in response to platelet-derived growth factor. J. Biol. Chem. 279 (2004) 17897-17904
100. Patrussi L., Savino M., Pellegrini M., Paccani S., Migliaccio E., Plyte S., Lanfrancone L., Pelicci P., and Baldari C. Cooperation and selectivity of the two Grb2 binding sites of p52Shc in T-cell antigen receptor signaling to Ras family GTPases and Myc-dependent survival. Oncogene 24 (2005) 2218-2228
101. Zhang S., Weinheimer C., Courtois M., Kovacs A., Zhang C., Cheng A., Wang Y., and Muslin A. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J. Clin. Invest. 111 (2003) 833-841
102. Gurusamy N., Watanabe K., Ma M., Zhang S., Muslin A., Kodama M., and Aizawa Y. Dominant negative 14-3-3 promotes cardiomyocyte apoptosis in early stage of type I diabetes mellitus through activation of JNK. Biochem. Biophys. Res. Commun. 320 (2004) 773-780
103. Santoro M., Gaudino G., and Marchisio P. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Dev. Cell 5 (2003) 257-271
104. Zhang S., Ren J., Zhang C., Treskov I., Wang Y., and Muslin A. Role of 14-3-3-mediated p38 mitogen-activated protein kinase inhibition in cardiac myocyte survival. Circ. Res. 93 (2003) 1026-1028
105. Kosaki A., Yamada K., Suga J., Otaka A., and Kuzuya H. 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3′-kinase activity in 3T3L1 adipocytes. J. Biol. Chem. 273 (1998) 940-944
106. Xiang X., Yuan M., Song Y., Ruderman N., Wen R., and Luo Z. 14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1. Mol. Endocrinol. 16 (2002) 552-562
107. Celi A., Pellegrini G., Lorenzet R., De Blasi A., Ready N., Furie B., and Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 8767-8771
108. Cooper D., Butcher C., Berndt M., and Vadas M. P-selectin interacts with a beta 2-integrin to enhance phagocytosis. J. Immunol. 153 (1994) 3199-3209
109. Kim Y., Borsig L., Varki N., and Varki A. P-selectin deficiency attenuates tumor growth and metastasis. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9325-9330
110. Hanley W., McCarty O., Jadhav S., Tseng Y., Wirtz D., and Konstantopoulos K. Single molecule characterization of P-selectin/ligand binding. J. Biol. Chem. 278 (2003) 10556-10561
111. Tozeren A., Kleinman H., Grant D., Morales D., Mercurio A., and Byers S. E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int. J. Cancer 60 (1995) 426-431